Cleared Traditional

K882943 - MEDA ONE-STEP

K882943 is an FDA 510(k) clearance for MEDA ONE-STEP, manufactured by Medical Electronic Assn.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 39-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
39d
Days
Class 2
Risk

K882943 is an FDA 510(k) clearance for the MEDA ONE-STEP. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medical Electronic Assn. (Englewood, US). The FDA issued a Cleared decision on August 19, 1988 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K882943

510(k) Number K882943 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 1988
Decision Date August 19, 1988
Days to Decision 39 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 149d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K882943.
ELECTROSTIMULATOR MODEL 808
K880426 · Cornell Enterprises Co., Inc. · Sep 1988
ALPHA-STIM 350
K881753 · Electromedical Products, Inc. · Aug 1988
MEDIPAC II EC (TM), MODEL 7900
K882820 · Medical Devices, Inc. · Aug 1988
INDICATENS 4X4
K881708 · Acudata Software · Aug 1988
ACUTRON
K880042 · Davis Assoc. · Aug 1988
DS-200 AND DS-400 T.E.N.S.
K881832 · Delta Marketing, Inc. · Jul 1988